deCODE genetics (Nasdaq:DCGN) has announced the launch of deCODE BreastCancer?, a new tool for assessing risk of the common forms of breast cancer. For the first time, a woman concerned about breast cancer can speak with her physician about a genetic test to better understand her lifetime risk of developing the common forms of the disease.
More...